Acute Porphyria Drug Database

Monograph

R03BA07 - Mometasone
Not porphyrinogenic
NP

Rationale
Probably insignificant systemic exposure. Several references stating non-porphyrinogenicity of glucocorticoids.
Chemical description
Glucocorticosteroid used (400-800 ug/d) in asthma. Not significantly absorbed from lung or gastrointestinal channel. Metabolized by CYP 3A4. glucocorticoids EPI-list: safe South African list: use Kalman, Bonkowski: safe The Merck Manual: safe Tschudy DP, Lamon JM: Porphyrin metabolism and the porphyrias, in Bondy PK, Rosenberg LE (eds.): Duncan's Diseases of Metabolism. Philadelphia, WB Saunders, 1980, p939: safe Moore MR, Hift RJ: Drugs in the acute porphyrias. Cell Mol Biol 43:89, 1997: safe

Similar drugs
Explore alternative drugs in similar therapeutic classes R03B / R03BA or go back.

Tradenames and packages
From some sources, we get a list of packages (United Kingdom, Ireland, Estonia). Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway). What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names are the searchable terms. The gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.
Belgium
Asmanex · Asmanex Twisthaler 200 µg pdr. inhal. récip. multidos. · Asmanex Twisthaler 400 µg pdr. inhal. récip. multidos.
United Kingdom
Asmanex · Asmanex 200micrograms/dose Twisthaler · Asmanex 400micrograms/dose Twisthaler
Denmark
Asmanex · Asmanex Twisthaler
Norway
Asmanex Twisthaler
Poland
Asmanex Twisthaler
Iceland
Asmanex · Asmanex Twisthaler
Finland
Asmanex Twisthaler
 
© NAPOS 2024
An unhandled error has occurred. Reload 🗙